Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice
- PMID: 15658002
- DOI: 10.1007/BF03033283
Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice
Abstract
Hyperphosphorylation and accumulation of tau in neurons (and glial cells) is one of the main pathologic hallmarks in Alzheimer's disease (AD) and other tauopathies, including Pick's disease (PiD), progressive supranuclear palsy, corticobasal degeneration, argyrophilic grain disease and familial frontotemporal dementia and parkinsonism linked to chromosome 17 due to mutations in the tau gene (FTDP-17-tau). Recent studies have shown increased expression of select active kinases, including stress-activated kinase, c-Jun N-terminal kinase (SAPK/JNK) and kinase p38 in brain homogenates in all the tauopathies. Strong active SAPK/JNK and p38 immunoreactivity has been observed restricted to neurons and glial cells containing hyperphosphorylated tau, as well as in dystrophic neurites of senile plaques in AD. Moreover, SAPK/JNK- and p38-immunoprecipitated sub-cellular fractions enriched in abnormal hyperphosphorylated tau have the capacity to phosphorylate recombinat tau and c-Jun and ATF-2 which are specific substrates of SAPK/JNK and p38 in AD and PiD. Interestingly, increased expression of phosphorylated SAPK/JNK and p38 in association with hyperphosphorylated tau containing neurites have been observed around betaA4 amyloid deposits in the brain of transgenic mice (Tg2576)carrying the double APP Swedish mutation. These findings suggest that betaA4 amyloid has the capacity to trigger the activation of stress kinases which, in turn, phosphorylate tau in neurites surrounding amyloid deposits. Reduction in the amyloid burden and decreased numbers of amyloid plaques but not of neurofibrillary degeneration has been observed in the brain of two AD patients who participated in an amyloid-beta immunization trial. Activation of stress kinases SAPK/JNK and p38 were reduced together with decreased tau hyperphosphorylation of aberrant neurites in association with decreased amyloid plaques. These findings support the amyloid cascade hypothesis of tau phosphorylation mediated by stress kinases in dystrophic neurites of senile plaques but not that of neurofibrillary tangles and neuropil threads in AD.
Similar articles
-
Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.Curr Alzheimer Res. 2005 Jan;2(1):3-18. doi: 10.2174/1567205052772713. Curr Alzheimer Res. 2005. PMID: 15977985 Review.
-
Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.J Neural Transm (Vienna). 2001;108(12):1397-415. doi: 10.1007/s007020100016. J Neural Transm (Vienna). 2001. PMID: 11810404
-
Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.Neuropathol Appl Neurobiol. 2004 Oct;30(5):491-502. doi: 10.1111/j.1365-2990.2004.00569.x. Neuropathol Appl Neurobiol. 2004. PMID: 15488025
-
Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.Acta Neuropathol. 2002 Dec;104(6):583-91. doi: 10.1007/s00401-002-0587-8. Epub 2002 Jul 13. Acta Neuropathol. 2002. PMID: 12410379
-
Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies.Int J Mol Sci. 2022 Oct 25;23(21):12841. doi: 10.3390/ijms232112841. Int J Mol Sci. 2022. PMID: 36361631 Free PMC article. Review.
Cited by
-
Characterization of thorn-shaped astrocytes in white matter of temporal lobe in Alzheimer's disease brains.Brain Pathol. 2013 Mar;23(2):144-53. doi: 10.1111/j.1750-3639.2012.00627.x. Epub 2012 Sep 13. Brain Pathol. 2013. PMID: 22882361 Free PMC article.
-
Neurotoxins and neurotoxicity mechanisms. An overview.Neurotox Res. 2006 Dec;10(3-4):263-87. doi: 10.1007/BF03033362. Neurotox Res. 2006. PMID: 17197375 Review.
-
Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases.PLoS Pathog. 2013 Sep;9(9):e1003537. doi: 10.1371/journal.ppat.1003537. Epub 2013 Sep 19. PLoS Pathog. 2013. PMID: 24068917 Free PMC article. Review. No abstract available.
-
Oxidative stress enhances neurodegeneration markers induced by herpes simplex virus type 1 infection in human neuroblastoma cells.PLoS One. 2013 Oct 4;8(10):e75842. doi: 10.1371/journal.pone.0075842. eCollection 2013. PLoS One. 2013. PMID: 24124518 Free PMC article.
-
MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease.Sci Rep. 2016 May 25;6:26697. doi: 10.1038/srep26697. Sci Rep. 2016. PMID: 27221467 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous